Literature DB >> 5093710

Depressed tolbutamide-induced insulin response in subjects treated with propranolol.

F Massara, E Strumia, F Camanni, G M Molinatti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5093710     DOI: 10.1007/bf01211881

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  11 in total

1.  Studies on the role of adenylcyclase in insulin secretion.

Authors:  R Bressler; M V Cordon; K Brendel
Journal:  Arch Intern Med       Date:  1969-03

2.  Tolbutamide and propranolol.

Authors:  O De Divitiis; F Giordano; B Gallo; A Jacono
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

3.  Role of adrenergic receptors in glucose-induced insulin secretion in man.

Authors:  E Cerasi; S Effendic; R Luft
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

4.  Beta-adrenergic stimulation and insulin release in dogs following HB 419.

Authors:  O V Sirek; M Vigas; A Niki; H Niki; A Sirek
Journal:  Diabetologia       Date:  1969-08       Impact factor: 10.122

5.  Beta-adrenergic receptors and the plasma acid response to insulin in man.

Authors:  D R London; M A Prenton
Journal:  Clin Sci       Date:  1968-08       Impact factor: 6.124

6.  Role of beta-adrenergic receptors in counterregulation to insulin-induced hypoglycemia.

Authors:  E A Abramson; R A Arky
Journal:  Diabetes       Date:  1968-03       Impact factor: 9.461

7.  Propranolol block of adrenaline-induced hypophosphataemia in man.

Authors:  F Massara; F Camanni
Journal:  Clin Sci       Date:  1970-02       Impact factor: 6.124

8.  Beta adrenergic stimulation of insulin release in man.

Authors:  D Porte
Journal:  Diabetes       Date:  1967-03       Impact factor: 9.461

9.  Persistence of the hypoglycemic effect of tolbutamide after block of beta-adrenergic receptors.

Authors:  S Erill
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-02

10.  A receptor mechanism for the inhibition of insulin release by epinephrine in man.

Authors:  D Porte
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

View more
  8 in total

1.  Insulin secretion during oral treatment with beta-adrenergic blocking agents in diabetics.

Authors: 
Journal:  Acta Diabetol Lat       Date:  1976 Jan-Apr

Review 2.  Formulary considerations in selection of beta-blockers.

Authors:  K C Yedinak
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

Review 3.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

4.  Betaxolol and glucose-insulin relationships: studies in normal subjects taking glibenclamide or metformin.

Authors:  A J Sinclair; I B Davies; S J Warrington
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

5.  Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas.

Authors:  J Iversen
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

Review 6.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

7.  B cell adrenoceptors and sulphonylurea-induced insulin release in mouse islets.

Authors:  M G Garrino; J C Henquin
Journal:  Diabetologia       Date:  1990-03       Impact factor: 10.122

8.  The effect of acebutolol and propranolol on the hypoglycaemic action of glibenclamide.

Authors:  R Zaman; M J Kendall; P I Biggs
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.